© 2000 by European Society of Cardiology
ATRIAL ARRHYTHMIAS
Efficacy and tolerability of continuous overdrive atrial pacing in atrial fibrillation
1Department of Medicine and Geriatrics, Kwong Wah Hospital Hong Kong; 2Department of Medicine and Institute of Cardiovascular Science and Medicine, University of Hong Kong, Queen Mary Hospital Hong Kong
Abstract
Overdrive right atrial pacing has been used to prevent atrial fibrillation, but its efficacy in atrial fibrillation prevention and the patient tolerability and quality of life during high rate pacing remain uncertain. The objective of this study was to test the effects of a consistent atrial pacing algorithm that automatically paced the atrium at 30 ms shorter than the sinus P–P interval for atrial fibrillation prevention. Fifteen patients with sick sinus syndrome implanted with a Thera DR (model 7940 or 7960, Medtronic Inc.) were randomly programmed to rate adaptive dual chamber pacing (DDDR) or DDDR+consistent atrial pacing mode, each for an 8-week study period. The efficacy of consistent atrial pacing was assessed by the number of automatic mode switching and the number of premature atrial complexes. Symptoms and quality of life were assessed by the SF-36 quality of life questionnaire and an atrial fibrillation symptom checklist. The percentage of atrial pacing increased from 57±32% to 86±28%. Overall, there was no significant difference in the number of automatic mode switching episodes between DDDR and DDDR+ consistent atrial pacing (47±90 vs 42±87, P> 0·05), but a significant reduction in premature atrial complexes by 74·7% (P< 0·001). There was no undue increase in atrial rate by the DDDR+consistent atrial pacing mode versus DDDR (63±13 vs 70±7 bpm). There was no significant difference in quality of life scores and symptom severity on frequency between the two modes of pacing, but a trend towards a lower frequency of symptoms in the DDDR+consistent atrial pacing mode compared with baseline (29·5±10·2 vs 25·1±9·7, P=0·07). An algorithm that provides consistent atrial overdrive pacing can suppress atrial fibrillation triggering premature atrial complexes without the need to increase the overall atrial rate compared with conventional pacing. The algorithm appears to be well-tolerated, but further studies are needed to address the clinical impact of this atrial fibrillation prevention algorithm.
Key Words: Atrial fibrillation, consistent atrial pacing, prevention of premature atrial complexes
Correspondence: Prof. C. P. Lau, Chief in Cardiology Division, Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong.
References
[1] Rosenqvist M, Brandt J, Schüller H. Long term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J 1988; 116: 16–22.[CrossRef][Web of Science][Medline]
[2] Stangl K, Seitz A, Wirtzfeld E, Blomer H. Difference between atrial single chamber pacing [AAI] and ventricular single chamber pacing [VVI] with respect to prognosis and antiarrhythmic effect in patients with sick sinus syndrome. Pacing Clin Electrophysiol 1990; 13: 2080–2085.[Medline]
[3] Anderson HR, Nielsen JC, Thomsen PE, Theusen L, Mortensen PT, Vesterlund T, Pedersen AK. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997; 350: 1210–1216.[CrossRef][Web of Science][Medline]
[4] Connolly SJ, Kerr C, Gent M, Yusuf S. Dual-chamber versus ventricular pacing. Critical appraisal of current data. Circulation 1996; 94: 578–583.
[5] Lamas GA, Orev J, Stambler BS, et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. N Engl J Med 1998; 338: 1097–1104.
[6] Connolly ST, Kerr CR, Gent M, et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med 2000; 342: 1385–1391.
[7] Attuel P, Pellerin J, Mugica J, Coumel PH. DDD pacing: an effective treatment modality for recurrent atrial arrhythmia. Pacing Clin Electrophysiol 1988; 11: 1647–1654.[CrossRef][Medline]
[8] Gillis AM, Wyse G, Connolly SJ, Dubuc M, Philippon F, Yee R, Lacombe P. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. Circulation 1999; 99: 2553–2558.
[9] Daubert C, Leclercq C, Le Breton H, Gras D, Pavin D, Pouvreau Y, Van Verooij P, Bakels N, Mabo P. Permanent left atrial pacing with a specifically designed coronary sinus lead. Pacing Clin Electrophysiol 1997; 20: 2755–2764.[CrossRef][Medline]
[10] Saksena S, Prakash A, Hill M, Krol RB, Munsif AN, Mathew PP. Prevention of recurrent atrial fibrillation with chronic atrial pacing. J Am Coll Cardiol 1996; 28: 687–694.[Abstract]
[11] Delfaut P, Saksena S, Prakash A, Krol RB. Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single and dual-site right atrial pacing for arrhythmia prevention. J Am Coll Cardiol 1998; 32,7: 1900–1908.
[12] Leclercq JF, Rosengarten MD, Delcourt Ph, Attuel P, Coumel Ph, Slama R. Prevention of intra-atrial reentry by chronic atrial pacing. Pacing Clin Electrophysiol 1980; 3: 162–170.[Medline]
[13] Ragonese P, Drago F, Guccione P, Santilli A, Silvetti MS, Agostino DA. Permanent overdrive atrial pacing in the chronic management of recurrent postoperative atrial reentrant tachycardia in patients with complex congenital heart disease. Pacing Clin Electrophysiol 1997; 20: 2917–2923.[CrossRef][Medline]
[14] Murgatroyd FD, Nitzsche R, Slade AKB, Limousin M, Rosset N, Camm AJ, Ritter P. A new pacing algorithm for overdrive suppression of atrial fibrillation. Pacing Clin Electrophysiol 1994; 17: 1966–1973.[CrossRef][Medline]
[15] Tse HF, Lau CP, Ayers GM. Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol. Heart 1999; 82: 319–324.
[16] Fitts SM, Hill MR, Mehra R, Friedman P, Hammill S, Kay GN, Prakash A, Webb C, Sakasena S. Design and implementation of the dual site atrial pacing to prevent atrial fibrillation (DAPPAF) clinical trial. DAPPAF phase 1 investigators. J Interv Card Electrophysiol 1998; 2: 139–144.[CrossRef][Web of Science][Medline]
[17] Mirza I, Gill J, Bucknall C, Holt P. Biatrial pacing in non-brady atrial fibrillation: Inter-atrial conduction delay as a selection criterion for successful prevention (abstract). Pacing Clin Electrophysiol 1999; 22: 803.
[18] Lau CP, Tse HF, Yu CM, Teo WS, Ng KH, Huang SK, Leung SK, Tsang V, Hill M. Dual site right atrial pacing in paroxysmal atrial fibrillation without bradycardia (NIPP-AF study) (abstract). Pacing Clin Electrophysiol 1999; 22: 804.
[19] Leung SK, Lau CP, Lam CTF, Tse HF, Tang MO, Chung F, Ayers G. Programmed atrial sensitivity: A critical determinant in atrial fibrillation detection and optimal automatic mode switching. Pacing Clin Electrophysiol 1998; 21: 2214–2219.[CrossRef][Medline]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A.J. Camm, N. Sulke, N. Edvardsson, P. Ritter, B.A. Albers, J.H. Ruiter, T. Lewalter, P.A. Capucci, E. Hoffmann, and on behalf of the AFTherapy investigators Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study Europace, December 1, 2007; 9(12): 1110 - 1118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sulke, J. Silberbauer, L. Boodhoo, N. Freemantle, K. Kamalvand, S. O'Nunain, D. Hildick-Smith, G. W. Lloyd, N. R. Patel, and V. Paul The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study Europace, September 1, 2007; 9(9): 790 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R A Archbold and R J Schilling Atrial pacing for the prevention of atrial fibrillation after coronary artery bypass graft surgery: a review of the literature Heart, February 1, 2004; 90(2): 129 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Carlson, J. Ip, J. Messenger, S. Beau, S. Kalbfleisch, P. Gervais, D. A. Cameron, A. Duran, J. Val-Mejias, J. Mackall, et al. A new pacemaker algorithm for the treatment of atrial fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT) J. Am. Coll. Cardiol., August 20, 2003; 42(4): 627 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kale and D. H. Bennett Pacemaker prevention therapies for the control of drug-refractory paroxysmal atrial fibrillation Europace, January 1, 2003; 5(2): 123 - 131. [Abstract] [PDF]
|
|
|
|
|
|
C.-P. Lau Pacing for atrial fibrillation Heart, January 1, 2003; 89(1): 106 - 112. [Full Text] [PDF]
|
|
|
|
|
|
A. G. Manolis, A. G. Katsivas, C. Vassilopoulos, D. Koutsogeorgis, and N. E. Louvros Prevention of atrial fibrillation by inter-atrial septum pacing guided by electrophysiological testing, in patients with delayed interatrial conduction Europace, January 1, 2002; 4(2): 165 - 174. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||